UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 6, 2019
BENEFITFOCUS, INC.
(Exact name of registrant as specified in its charter)
|
|
Delaware (State or other jurisdiction of incorporation) |
|
|
|
|
|
|
001-36061 |
|
46-2346314 |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
100 Benefitfocus Way, Charleston, South Carolina 29492
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (843) 849-7476
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
Common Stock, $0.001 Par Value |
|
BNFT |
|
Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this Chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this Chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On August 6, 2019, Benefitfocus, Inc. issued a press release announcing its operating results for the quarter ended June 30, 2019. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.
The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press release dated August 6, 2019
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
BENEFITFOCUS, INC. |
|
|
|
|
|
Date: August 6, 2019 |
|
/s/ Lou Anne Gilmore |
|
|
|
Lou Anne Gilmore |
|
|
|
Vice President of Corporate Development and former Interim Chief Financial Officer (Principal financial and accounting officer) |
Exhibit 99.1
|
Benefitfocus, Inc. 843-284-1052 ext. 3527 pr@benefitfocus.com
Investor Relations: Michael Bauer 843-284-1052 ext. 6654 michael.bauer@benefitfocus.com |
|
|
|
|
|
|
Benefitfocus Announces Second Quarter 2019 Financial Results
Driven by its leading AI-powered Platform, Benefitfocus grew total revenue 13% year-over-year
Charleston, S.C. – August 6, 2019 – Benefitfocus, Inc. (NASDAQ: BNFT), a leading cloud-based benefits management platform and services provider, today announced its second quarter 2019 financial results. Recent highlights include:
|
|
• |
Grew net benefit eligible lives to 16.5 million at the end of the second quarter, up from 15.5 million at the end of the prior quarter and 12.3 million at the end of the prior year period. |
|
|
• |
Expanded BenefitsPlace™ to 50 suppliers, up from 18 at the prior year period. |
|
|
• |
Launched enterprise HCM API data exchange capabilities. |
|
|
• |
Strengthened executive leadership with appointment of Stephen M. Swad as Chief Financial Officer and Steve Malme as Senior Vice President of Platform Strategy. |
“With our leading AI-powered platform for benefits, we are creating significant economic value and delivering growth and innovation through our platform strategy,” said Ray August, President and Chief Executive Officer of Benefitfocus. “In Q2, we added approximately 1 million net benefit eligible lives. This was our strongest quarter to date for growing lives on our platform. We are removing points of friction and further advancing our platform’s capabilities by automating inefficient, manual processes across our ecosystem. Our intelligence engine is improving user experience, helping consumers make better, smarter decisions. All of this helps drive growth and contributed to our strong second quarter financial results.”
Second Quarter 2019 Financial Highlights
Revenue
|
|
• |
Total revenue was $68.6 million, an increase of 13% compared to the second quarter of 2018. |
|
|
• |
Software services revenue was $53.1 million, an increase of 10% compared to the second quarter of 2018. |
|
|
• |
Professional services revenue was $15.5 million, an increase of 26% compared to the second quarter of 2018. |
Net Loss
|
|
• |
GAAP net loss was ($14.9) million, compared to ($14.3) million in the second quarter of 2018. GAAP net loss per share was ($0.46), based on 32.6 million basic and diluted weighted average common shares outstanding, compared to ($0.45) for the second quarter of 2018, based on 31.8 million basic and diluted weighted average common shares outstanding. |
Non-GAAP Net Loss and Adjusted EBITDA
|
|
• |
Non-GAAP net loss was ($10.0) million, compared to ($7.7) million in the second quarter of 2018. Non-GAAP net loss per share was ($0.31), based on 32.6 million basic and diluted weighted average common shares outstanding, compared to ($0.24) for the second quarter of 2018, based on 31.8 million basic and diluted weighted average common shares outstanding. |
|
|
• |
Adjusted EBITDA was $0.1 million, compared to ($0.6) million in the second quarter of 2018. |
See important disclosures about non-GAAP measures, and a reconciliation of them to GAAP, below.
|
|
• |
Cash and cash equivalents at June 30, 2019 totaled $138.4 million, compared to $144.2 million at the end of the first quarter of 2019. |
Updated Business Outlook
Based on information available as of August 6, 2019, Benefitfocus is providing guidance for the third quarter and updated its full year 2019 as indicated below.
Third Quarter 2019:
|
|
• |
Total revenue is expected to be in the range of $70.0 million to $72.0 million. |
|
|
• |
Non-GAAP net loss is expected to be in the range of ($14.0) million to ($12.0) million, or ($0.43) to ($0.37) per share, based on 32.7 million basic and diluted weighted average common shares outstanding. |
|
|
• |
Adjusted EBITDA is expected to be in the range of ($3.5) million to ($1.5) million. |
Full Year 2019:
|
|
• |
Total revenue is expected to be in the range of $292.0 million to $300.0 million. |
|
|
• |
Non-GAAP net loss is expected to be in the range of ($31.0) million to ($26.0) million, or ($0.95) to ($0.80) per share, based on 32.5 million basic and diluted weighted average common shares outstanding. |
|
|
• |
Adjusted EBITDA is expected to be in the range of $10.0 million to $15.0 million. |
Management has not reconciled forward-looking non-GAAP net loss and Adjusted EBITDA to their most directly comparable GAAP measure of GAAP net loss. Management is unable to predict with reasonable certainty the ultimate outcome of the various necessary GAAP components of such reconciliations, including, for example, those related to compensation, acquisition transactions and integration, or others that may arise during the year, without unreasonable effort. These components and other factors could materially impact the amount of the future directly comparable GAAP measures, which may differ significantly from their non-GAAP counterparts. See below for additional important disclosures regarding our non-GAAP financial measures.
Conference Call Details:
In conjunction with this announcement, Benefitfocus will host a conference call today, August 6, 2019, at 5:00 p.m. Eastern Time to discuss the company’s financial results. To access this call, dial (877) 407-9208 (domestic) or (201) 493-6784 (international). A live webcast, as well as the replay, of the conference call will be available on the Investor Relations page of the company’s website at http://investor.benefitfocus.com/. After the conference call, a replay will be available until August 13, 2019, and can be accessed by dialing (844) 512-2921 (domestic) or (412) 317-6671 (international) with passcode 13692514.
About Benefitfocus
Benefitfocus (NASDAQ: BNFT) unifies the entire U.S. benefits industry on a single technology platform to protect consumers' health, wealth, property and lifestyle. Our powerful cloud-based software, data-driven insights and thoughtfully-designed services, enable employers, insurance brokers, carriers and suppliers to simplify the complexity of benefits administration and deliver a world-class benefits experience. Learn more at www.benefitfocus.com, LinkedIn and Twitter.
Non-GAAP Financial Measures
The company uses certain non-GAAP financial measures in this release, including non-GAAP gross profit, operating loss, net loss, net loss per common share, and adjusted EBITDA. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance or financial position that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.
Non-GAAP gross profit, operating loss, net loss and net loss per common share exclude stock-based compensation expenses, amortization of acquisition-related intangible assets, transaction and acquisition-related costs expensed, if any, and costs not core to our business, if any. We define adjusted EBITDA as net loss before net interest, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense, expense related to the impairment of goodwill and intangible assets, transaction and acquisition-related costs expensed, and costs not core to our business. Please note that other companies might define their non-GAAP financial measures differently than we do.
Management presents these non-GAAP financial measures in this release because it considers them to be important supplemental measures of performance. Management uses these non-GAAP financial measures for planning purposes, including analysis of the company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management believes that these non-GAAP financial measures provide additional insight for analysts and investors in evaluating the company's financial and operational performance. Management also intends to provide these non-GAAP financial measures as part of the company’s future earnings discussions and, therefore, their inclusion should provide consistency in the company’s financial reporting.
Non-GAAP financial measures have limitations as an analytical tool. Investors are encouraged to review the reconciliation of the non-GAAP measures to their most directly comparable GAAP measures provided in this release, including in the accompanying tables.
Safe Harbor Statement
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: our continuing losses and need to achieve GAAP profitability; fluctuations in our financial results; the immature and volatile market for our products and services; risks related to changing healthcare and other applicable regulations; risks associated with acquisitions; our ability to maintain our culture, recruit and retain qualified personnel and effectively expand our sales force; cyber-security risks; the need to innovate and provide useful products and services; our ability to compete effectively; privacy, security and other risks associated with our business; and the other risk factors set forth from time to time in our SEC filings, copies of which are available free of charge within the Investor Relations section of the Benefitfocus website at http://investor.benefitfocus.com/sec-filings or upon request from our Investor Relations Department. Benefitfocus assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
Source: Benefitfocus, Inc.
Unaudited Consolidated Statements of Operations and Comprehensive Loss
(in thousands, except share and per share data)
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
||||
|
Revenue |
|
$ |
68,579 |
|
|
$ |
60,581 |
|
|
$ |
136,878 |
|
|
$ |
122,944 |
|
|
Cost of revenue (1)(2)(3) |
|
|
32,802 |
|
|
|
30,721 |
|
|
|
65,654 |
|
|
|
62,124 |
|
|
Gross profit |
|
|
35,777 |
|
|
|
29,860 |
|
|
|
71,224 |
|
|
|
60,820 |
|
|
Operating expenses:(1)(2)(3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
19,318 |
|
|
|
18,400 |
|
|
|
38,937 |
|
|
|
38,317 |
|
|
Research and development |
|
|
14,461 |
|
|
|
12,128 |
|
|
|
27,551 |
|
|
|
24,151 |
|
|
General and administrative |
|
|
11,785 |
|
|
|
10,387 |
|
|
|
23,581 |
|
|
|
20,080 |
|
|
Total operating expenses |
|
|
45,564 |
|
|
|
40,915 |
|
|
|
90,069 |
|
|
|
82,548 |
|
|
Loss from operations |
|
|
(9,787 |
) |
|
|
(11,055 |
) |
|
|
(18,845 |
) |
|
|
(21,728 |
) |
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
762 |
|
|
|
68 |
|
|
|
1,422 |
|
|
|
126 |
|
|
Interest expense |
|
|
(5,837 |
) |
|
|
(1,415 |
) |
|
|
(11,651 |
) |
|
|
(2,732 |
) |
|
Interest expense on building lease financing obligations |
|
|
– |
|
|
|
(1,867 |
) |
|
|
– |
|
|
|
(3,733 |
) |
|
Other (expense) income |
|
|
(73 |
) |
|
|
13 |
|
|
|
(64 |
) |
|
|
13 |
|
|
Total other expense, net |
|
|
(5,148 |
) |
|
|
(3,201 |
) |
|
|
(10,293 |
) |
|
|
(6,326 |
) |
|
Loss before income taxes |
|
|
(14,935 |
) |
|
|
(14,256 |
) |
|
|
(29,138 |
) |
|
|
(28,054 |
) |
|
Income tax expense |
|
|
3 |
|
|
|
5 |
|
|
|
9 |
|
|
|
9 |
|
|
Net loss |
|
$ |
(14,938 |
) |
|
$ |
(14,261 |
) |
|
$ |
(29,147 |
) |
|
$ |
(28,063 |
) |
|
Comprehensive loss |
|
$ |
(14,938 |
) |
|
$ |
(14,261 |
) |
|
$ |
(29,147 |
) |
|
$ |
(28,063 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
$ |
(0.46 |
) |
|
$ |
(0.45 |
) |
|
$ |
(0.90 |
) |
|
$ |
(0.89 |
) |
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
32,613,718 |
|
|
|
31,806,972 |
|
|
|
32,336,864 |
|
|
|
31,571,468 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Stock-based compensation included in above line items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue |
|
$ |
691 |
|
|
$ |
900 |
|
|
$ |
1,590 |
|
|
$ |
1,611 |
|
|
Sales and marketing |
|
|
(12 |
) |
|
|
1,257 |
|
|
|
1,674 |
|
|
|
2,211 |
|
|
Research and development |
|
|
718 |
|
|
|
841 |
|
|
|
1,910 |
|
|
|
1,609 |
|
|
General and administrative |
|
|
2,322 |
|
|
|
1,676 |
|
|
|
4,912 |
|
|
|
3,568 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) Amortization of acquired intangible assets included in above line items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue |
|
$ |
308 |
|
|
$ |
35 |
|
|
$ |
407 |
|
|
$ |
69 |
|
|
Sales and marketing |
|
|
113 |
|
|
|
13 |
|
|
|
149 |
|
|
|
27 |
|
|
Research and development |
|
|
131 |
|
|
|
11 |
|
|
|
171 |
|
|
|
23 |
|
|
General and administrative |
|
|
53 |
|
|
|
5 |
|
|
|
68 |
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) Transaction and acquisition-related costs expensed included in above line items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative |
|
$ |
360 |
|
|
$ |
257 |
|
|
$ |
1,002 |
|
|
$ |
257 |
|
Unaudited Consolidated Balance Sheets
(in thousands, except share and per share data)
|
|
|
As of June 30, 2019 |
|
|
As of December 31, 2018 |
|
||
|
Assets |
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
138,389 |
|
|
$ |
190,928 |
|
|
Accounts receivable, net |
|
|
32,395 |
|
|
|
21,077 |
|
|
Contract, prepaid and other current assets |
|
|
17,070 |
|
|
|
16,667 |
|
|
Total current assets |
|
|
187,854 |
|
|
|
228,672 |
|
|
Property and equipment, net |
|
|
28,803 |
|
|
|
69,965 |
|
|
Financing lease right-of-use assets |
|
|
78,856 |
|
|
|
– |
|
|
Operating lease right-of-use assets |
|
|
2,020 |
|
|
|
– |
|
|
Intangible assets, net |
|
|
13,804 |
|
|
|
– |
|
|
Goodwill |
|
|
12,857 |
|
|
|
1,634 |
|
|
Deferred contract costs and other non-current assets |
|
|
11,044 |
|
|
|
13,668 |
|
|
Total assets |
|
$ |
335,238 |
|
|
$ |
313,939 |
|
|
Liabilities and stockholders' deficit |
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
6,623 |
|
|
$ |
8,687 |
|
|
Accrued expenses |
|
|
9,217 |
|
|
|
11,461 |
|
|
Accrued compensation and benefits |
|
|
15,358 |
|
|
|
17,269 |
|
|
Deferred revenue, current portion |
|
|
36,937 |
|
|
|
36,540 |
|
|
Lease liabilities and financing obligations, current portion |
|
|
6,245 |
|
|
|
4,486 |
|
|
Total current liabilities |
|
|
74,380 |
|
|
|
78,443 |
|
|
Deferred revenue, net of current portion |
|
|
9,613 |
|
|
|
9,323 |
|
|
Convertible senior notes |
|
|
182,234 |
|
|
|
176,692 |
|
|
Lease liabilities and financing obligations, net current portion |
|
|
87,952 |
|
|
|
57,116 |
|
|
Other non-current liabilities |
|
|
138 |
|
|
|
2,575 |
|
|
Total liabilities |
|
|
354,317 |
|
|
|
324,149 |
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
Stockholders' deficit: |
|
|
|
|
|
|
|
|
|
Preferred stock, par value $0.001, 5,000,000 shares authorized, no shares issued and outstanding at June 30, 2019 and December 31, 2018 |
|
|
– |
|
|
|
– |
|
|
Common stock, par value $0.001, 50,000,000 shares authorized, 32,642,706 and 32,017,773 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively |
|
|
33 |
|
|
|
32 |
|
|
Additional paid-in capital |
|
|
416,221 |
|
|
|
403,631 |
|
|
Accumulated deficit |
|
|
(435,333 |
) |
|
|
(413,873 |
) |
|
Total stockholders' deficit |
|
|
(19,079 |
) |
|
|
(10,210 |
) |
|
Total liabilities and stockholders' deficit |
|
$ |
335,238 |
|
|
$ |
313,939 |
|
Benefitfocus, Inc.
Unaudited Consolidated Statements of Cash Flows
(in thousands)
|
|
|
Six Months Ended June 30, |
|
|||||
|
|
|
2019 |
|
|
2018 |
|
||
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(29,147 |
) |
|
$ |
(28,063 |
) |
|
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: |
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
10,949 |
|
|
|
7,957 |
|
|
Stock-based compensation expense |
|
|
10,086 |
|
|
|
8,999 |
|
|
Accretion of interest on convertible senior notes |
|
|
5,541 |
|
|
|
– |
|
|
Interest accrual on financing obligations (prior to adoption of ASC 842) |
|
|
– |
|
|
|
3,758 |
|
|
Rent expense in excess of payments |
|
|
3 |
|
|
|
– |
|
|
Provision for doubtful accounts |
|
|
265 |
|
|
|
364 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
Accounts receivable, net |
|
|
(10,671 |
) |
|
|
2,956 |
|
|
Contract, prepaid and other current assets |
|
|
(476 |
) |
|
|
2,182 |
|
|
Deferred costs and other non-current assets |
|
|
2,851 |
|
|
|
2,003 |
|
|
Accounts payable and accrued expenses |
|
|
(4,085 |
) |
|
|
(1,110 |
) |
|
Accrued compensation and benefits |
|
|
273 |
|
|
|
458 |
|
|
Deferred revenue |
|
|
(6,004 |
) |
|
|
(4,059 |
) |
|
Other non-current liabilities |
|
|
(46 |
) |
|
|
(218 |
) |
|
Net cash and cash equivalents used in operating activities |
|
|
(20,461 |
) |
|
|
(4,773 |
) |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
|
Business combination, net of cash acquired |
|
|
(20,914 |
) |
|
|
– |
|
|
Purchases of property and equipment |
|
|
(7,401 |
) |
|
|
(3,561 |
) |
|
Net cash and cash equivalents used in investing activities |
|
|
(28,315 |
) |
|
|
(3,561 |
) |
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
|
Draws on revolving line of credit |
|
|
– |
|
|
|
59,000 |
|
|
Payments on revolving line of credit |
|
|
– |
|
|
|
(48,000 |
) |
|
Payments of debt issuance costs |
|
|
(357 |
) |
|
|
– |
|
|
Proceeds from exercises of stock options and ESPP |
|
|
134 |
|
|
|
270 |
|
|
Payments on capital lease and financing obligations |
|
|
(841 |
) |
|
|
(4,979 |
) |
|
Payments of principal on financing lease obligations |
|
|
(2,699 |
) |
|
|
– |
|
|
Net cash and cash equivalents (used in) provided by financing activities |
|
|
(3,763 |
) |
|
|
6,291 |
|
|
Net decrease in cash and cash equivalents |
|
|
(52,539 |
) |
|
|
(2,043 |
) |
|
Cash and cash equivalents, beginning of period |
|
|
190,928 |
|
|
|
55,335 |
|
|
Cash and cash equivalents, end of period |
|
$ |
138,389 |
|
|
$ |
53,292 |
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of non-cash investing and financing activities |
|
|
|
|
|
|
|
|
|
Property and equipment purchases in accounts payable and accrued expenses |
|
$ |
437 |
|
|
$ |
272 |
|
|
Property and equipment purchased with financing and capital lease obligations |
|
$ |
— |
|
|
$ |
3,085 |
|
|
Post contract support purchased with financing obligations |
|
$ |
— |
|
|
$ |
275 |
|
Unaudited Reconciliation of GAAP to Non-GAAP Measures
(in thousands, except share and per share data)
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
||||
|
Reconciliation from Gross Profit to Non-GAAP Gross Profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
35,777 |
|
|
$ |
29,860 |
|
|
$ |
71,224 |
|
|
$ |
60,820 |
|
|
Amortization of acquired intangible assets |
|
|
308 |
|
|
|
35 |
|
|
|
407 |
|
|
|
69 |
|
|
Stock-based compensation expense |
|
|
691 |
|
|
|
900 |
|
|
|
1,590 |
|
|
|
1,611 |
|
|
Total net adjustments |
|
|
999 |
|
|
|
935 |
|
|
|
1,997 |
|
|
|
1,680 |
|
|
Non-GAAP gross profit |
|
$ |
36,776 |
|
|
$ |
30,795 |
|
|
$ |
73,221 |
|
|
$ |
62,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation from Operating Loss to Non-GAAP Operating Loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
$ |
(9,787 |
) |
|
$ |
(11,055 |
) |
|
$ |
(18,845 |
) |
|
$ |
(21,728 |
) |
|
Amortization of acquired intangible assets |
|
|
605 |
|
|
|
64 |
|
|
|
795 |
|
|
|
128 |
|
|
Stock-based compensation expense |
|
|
3,719 |
|
|
|
4,674 |
|
|
|
10,086 |
|
|
|
8,999 |
|
|
Transaction and acquisition-related costs expensed |
|
|
360 |
|
|
|
257 |
|
|
|
1,002 |
|
|
|
257 |
|
|
Costs not core to our business |
|
|
266 |
|
|
|
1,524 |
|
|
|
586 |
|
|
|
2,895 |
|
|
Total net adjustments |
|
|
4,950 |
|
|
|
6,519 |
|
|
|
12,469 |
|
|
|
12,279 |
|
|
Non-GAAP operating loss |
|
$ |
(4,837 |
) |
|
$ |
(4,536 |
) |
|
$ |
(6,376 |
) |
|
$ |
(9,449 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation from Net Loss to Adjusted EBITDA: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(14,938 |
) |
|
$ |
(14,261 |
) |
|
$ |
(29,147 |
) |
|
$ |
(28,063 |
) |
|
Depreciation |
|
|
3,690 |
|
|
|
2,999 |
|
|
|
7,657 |
|
|
|
5,976 |
|
|
Amortization of software development costs |
|
|
1,319 |
|
|
|
964 |
|
|
|
2,497 |
|
|
|
1,853 |
|
|
Amortization of acquired intangible assets |
|
|
605 |
|
|
|
64 |
|
|
|
795 |
|
|
|
128 |
|
|
Interest income |
|
|
(762 |
) |
|
|
(68 |
) |
|
|
(1,422 |
) |
|
|
(126 |
) |
|
Interest expense |
|
|
5,837 |
|
|
|
1,415 |
|
|
|
11,651 |
|
|
|
2,732 |
|
|
Interest expense on building lease financing obligations |
|
|
— |
|
|
|
1,867 |
|
|
|
— |
|
|
|
3,733 |
|
|
Income tax expense |
|
|
3 |
|
|
|
5 |
|
|
|
9 |
|
|
|
9 |
|
|
Stock-based compensation expense |
|
|
3,719 |
|
|
|
4,674 |
|
|
|
10,086 |
|
|
|
8,999 |
|
|
Transaction and acquisition-related costs expensed |
|
|
360 |
|
|
|
257 |
|
|
|
1,002 |
|
|
|
257 |
|
|
Costs not core to our business |
|
|
266 |
|
|
|
1,524 |
|
|
|
586 |
|
|
|
2,895 |
|
|
Total net adjustments |
|
|
15,037 |
|
|
|
13,701 |
|
|
|
32,861 |
|
|
|
26,456 |
|
|
Adjusted EBITDA |
|
$ |
99 |
|
|
$ |
(560 |
) |
|
$ |
3,714 |
|
|
$ |
(1,607 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation from Net Loss to Non-GAAP Net Loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(14,938 |
) |
|
$ |
(14,261 |
) |
|
$ |
(29,147 |
) |
|
$ |
(28,063 |
) |
|
Amortization of acquired intangible assets |
|
|
605 |
|
|
|
64 |
|
|
|
795 |
|
|
|
128 |
|
|
Stock-based compensation expense |
|
|
3,719 |
|
|
|
4,674 |
|
|
|
10,086 |
|
|
|
8,999 |
|
|
Transaction and acquisition-related costs expensed |
|
|
360 |
|
|
|
257 |
|
|
|
1,002 |
|
|
|
257 |
|
|
Costs not core to our business |
|
|
266 |
|
|
|
1,524 |
|
|
|
586 |
|
|
|
2,895 |
|
|
Total net adjustments |
|
|
4,950 |
|
|
|
6,519 |
|
|
|
12,469 |
|
|
|
12,279 |
|
|
Non-GAAP net loss |
|
$ |
(9,988 |
) |
|
$ |
(7,742 |
) |
|
$ |
(16,678 |
) |
|
$ |
(15,784 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Calculation of Non-GAAP Earnings Per Share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net loss |
|
$ |
(9,988 |
) |
|
$ |
(7,742 |
) |
|
$ |
(16,678 |
) |
|
$ |
(15,784 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic and diluted |
|
|
32,613,718 |
|
|
|
31,806,972 |
|
|
|
32,336,864 |
|
|
|
31,571,468 |
|
|
Shares used in computing non-GAAP net loss per share - basic and diluted |
|
|
32,613,718 |
|
|
|
31,806,972 |
|
|
|
32,336,864 |
|
|
|
31,571,468 |
|
|
Non-GAAP net loss per common share - basic and diluted |
|
$ |
(0.31 |
) |
|
$ |
(0.24 |
) |
|
$ |
(0.52 |
) |
|
$ |
(0.50 |
) |